Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1441 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.040 | 1.000 | 4 | 2009 | 2015 | ||||
Primary malignant neoplasm
|
1374 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.040 | 1.000 | 4 | 2009 | 2015 | ||||
Liver carcinoma
|
769 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.030 | 0.667 | 3 | 2012 | 2019 | ||||
Breast Carcinoma
|
2145 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.020 | 1.000 | 2 | 2005 | 2012 | ||||
Malignant neoplasm of breast
|
2154 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.020 | 1.000 | 2 | 2005 | 2012 | ||||
Arthritis, Psoriatic
|
50 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Carcinoma of lung
|
995 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Cholecystolithiasis
|
32 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Cholelithiasis
|
61 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Colorectal Carcinoma
|
1186 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Gallbladder Carcinoma
|
65 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Head and Neck Carcinoma
|
118 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Hepatitis C
|
316 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Lhermitte-Duclos disease
|
26 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Lumbar disc disease
|
30 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Lymphoma, Follicular
|
60 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant Head and Neck Neoplasm
|
117 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Malignant neoplasm of gallbladder
|
65 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Malignant neoplasm of lung
|
1000 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Primary malignant neoplasm of lung
|
981 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Recession
|
2 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Rheumatoid Arthritis
|
676 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Salivary Gland Pleomorphic Adenoma
|
9 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.645 | 0.440 | 8 | 23201811 | missense variant | C/G | snv | 0.54 | 0.44 | 0.010 | 1.000 | 1 | 2014 | 2014 |